Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples